EUVIMEDEUVIMED entdecken
Open Access

Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis

Chirag Raparia, Paul Hoover, Junting Ai, Marcus Clark, Sujal Shah, Accelerating Medicines Partnership (AMP): RA/SLE Network, Betty Diamond, Nir Hacohen, Arnon Arazi, Anne Davidson

Annals of the Rheumatic Diseases · 2026-08

DOI: 10.1016/j.ard.2026.07.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026-08. Verfasst von Chirag Raparia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Medicine, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA; Division of Rheumatology, Brigh…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIDDK NIH HHS, NIAID NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE), leading to progressive renal fibrosis and functional decline. Understanding the interplay between immune cells and stromal cells is needed to develop effective therapeutic strategies. In this study, we investigated the landscape of macrophage-fibroblast interactions in human LN and validated these findings in mouse models. METHODS: We characterised distinct fibroblast subsets and their interactions with renal macrophages using single-cell RNA sequencing of 156 human LN biopsies and 30 healthy controls from the Accelerating Medicines Partnership-SLE cohort, and spatial transcriptomics of biopsies from 6 patients with LN. In vitro coculture studies using mouse models were performed to further define functional consequences of these interactions. RESULTS: We identified 2 myofibroblast subsets: a proinflammatory subset (Myofib1) enriched in the tubulointerstitium, and a fibrotic/remodelling subset (Myofib2) in glomeruli, both correlating with the histologic chronicity index. Spatial transcriptomics revealed different colocalisation patterns, with Myofib1 interacting with activated resident macrophage (RM) subsets and Myofib2 with glomerular infiltrating disease-associated macrophages. In vitro coculture studies demonstrated that nephritic RMs promote a proinflammatory, remodelling fibroblast phenotype that impairs wound healing and drives a Myofib1-like gene programme, whereas disease-associated macrophages generated profibrotic fibroblasts with dysregulated reparative capacity. Cell-cell communication analyses identified key ligand-receptor interactions mediating this crosstalk, including Spp1/integrins, Sema4/PlexinB, and nicotinamide phosphoribosyl transferase/INSR. CONCLUSIONS: Our data reveal a spatially and functionally heterogeneous landscape of macrophage-fibroblast crosstalk in LN. These findings advance our understanding of renal fibrogenesis in LN, highlighting specific fibroinflammatory circuits that may represent therapeutic targets to prevent chronic renal damage.

Autor:innen und Institutionen

  • Institute of Molecular Medicine, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA; Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Division of Rheumatology, University of Chicago, Chicago, IL, USA.
  • Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Institute of Molecular Medicine, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
  • Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.

Förderung

  • NIAMS NIH HHS
  • NIDDK NIH HHS
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institutes of Health

Zitieren

APA

Raparia, C., Hoover, P., Ai, J., Clark, M., Shah, S., Accelerating Medicines Partnership (AMP): RA/SLE Network, Diamond, B., Hacohen, N., Arazi, A., & Davidson, A. (2026). Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.07.014

Vancouver

Raparia C, Hoover P, Ai J, Clark M, Shah S, Accelerating Medicines Partnership (AMP): RA/SLE Network, et al. Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2026.07.014

BibTeX
@article{Raparia2026,
  author = {Raparia, Chirag and Hoover, Paul and Ai, Junting and Clark, Marcus and Shah, Sujal and Accelerating Medicines Partnership (AMP): RA/SLE Network, Accelerating Medicines Partnership (AMP): RA/SLE Network and Diamond, Betty and Hacohen, Nir and Arazi, Arnon and Davidson, Anne},
  title = {Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  doi = {10.1016/j.ard.2026.07.014}
}
Kostenlos starten →